Overview Assessing the Safety and Efficacy of MK-5592 (Posaconazole) in Japanese Participants With Fungal Infection (MK-5592-101) Status: Completed Trial end date: 2018-01-24 Target enrollment: Participant gender: Summary The primary objective of this study is to assess and compare the safety of posaconazole with voriconazole in Japanese participants with aspergillosis. Phase: Phase 3 Details Lead Sponsor: Merck Sharp & Dohme Corp.Treatments: Pharmaceutical SolutionsPosaconazoleVoriconazole